Overall rank by patents
#2,025
of 49,997 tracked assignees
USPTO PatentsView assignee record - 197 granted patents across 36 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, Psiquantum ranks #2,025 of 49,997 tracked US assignees by granted-patent volume, with 197 patents across 36 technology areas.
USPTO PatentsView assignee plate
Corpus R2025 · US Corporation #2,025 · 197 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Abiomed, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
ASM IP Holding B V · near
68 score
PsiQuantum · this assignee
68 score
Transportation IP… · near
68 score
Wonderland Switzerland · near
68 score
Gyrus Acmi · near
68 score
3D Lighting… · lowest
7 score
What this shows Psiquantum's Innovation Score is 67.8/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
PsiQuantum Corp. is a focused PatentsView assignee: 36 CPC subclasses with 35.5% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2023 (41 grants) versus a trough of 10 in 2019. By volume, Psiquantum sits between Abiomed, Inc. and Biomet Sports Medicine, LLC.
From 2019–2021 to 2022–2024, PsiQuantum Corp. moved from 43 to 113 grants (2.63x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #108. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Abiomed, Inc.
197 patents
Intersil Americas LLC
197 patents
Oculus VR, LLC
197 patents
Pismo Labs Technology Limited
197 patents
Sorin CRM SAS
197 patents
Securus Technologies, LLC
197 patents
Timotion Technology Co., Ltd.
197 patents
PsiQuantum Corp.
197 patents
Biomet Sports Medicine, LLC
196 patents
What this shows PsiQuantum holds 197 patents at rank #2,025, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,025 in granted patent volume.
Other assignees with the most granted patents in PsiQuantum's primary technology class.
Two PlainPatent-derived peer sets for PsiQuantum, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (68 here).
Nearest assignees by average claims per patent (18.0 here).
Psiquantum's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
68 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 10 | 5.1% |
| 2020 | 12 | 6.1% |
| 2021 | 21 | 10.7% |
| 2022 | 33 | 16.8% |
| 2023 | 41 | 20.8% |
| 2024 | 39 | 19.8% |
| 2025partial year | 41 | 20.8% |
Top 15 of 36 technology areas
Overall rank by patents
#2,025
of 49,997 tracked assignees
67.8 out of 100
What to do with this data
PsiQuantum Corp.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.